Drug Profile
SP 0173
Alternative Names: Diphtheria/Pertusis/Tetnus vaccine - Sanofi; DTaP vaccine - Sanofi; SP0173; Tdap vaccine - SanofiLatest Information Update: 08 Apr 2022
Price :
$50
*
At a glance
- Originator Sanofi Pasteur
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Diphtheria; Pertussis; Tetanus
Most Recent Events
- 29 Oct 2020 Discontinued - Phase-I for Diphtheria (Prevention) in Canada (IM)
- 29 Oct 2020 Discontinued - Phase-I for Pertussis (Prevention) in Canada (IM)
- 29 Oct 2020 Discontinued - Phase-I for Tetanus (Prevention) in Canada (IM)